Skip to main content
SpringerLink
Log in

Phase Ib Single- and Multiple-Dose Pharmacokinetic Study of Oral NV-52 in Healthy Volunteers

  • Original Research Article
  • Published:
Drugs in R & D Aims and scope Submit manuscript

Abstract

Background and objective: NV-52 is a novel synthetic flavonoid thromboxane synthase (TXS) inhibitor that may be useful for the maintenance of remission in inflammatory bowel disease (IBD). This study was conducted to determine the single- and multiple-dose pharmacokinetics of NV-52 in nine healthy volunteers (five men, four women; mean [± SD] age 23 ± 2 years).p

Methods: NV-52 400 mg was administered once daily for 10 days (excluding day 2) in an open-label study. Plasma was sampled and urine was collected for 48 hours after the first and last doses. Plasma and urine unconjugated and total (unconjugated plus glucuronide and sulphate conjugated) NV-52 concentrations were measured using liquid chromatography-mass spectrometry.

Results: No adverse events were observed. Unconjugated and total NV-52 appeared and rose rapidly in plasma following the first dose. Time to maximum concentration values were 1.92 ± 1.17 and 2.72 ± 1.52 hours for unconjugated and total NV-52, respectively. Unconjugated and total NV-52 were eliminated with plasma half-lives of 13.12 ± 17.31 and 18.03 ± 19.06 hours, respectively, following the first dose. Pre-dose levels following multiple-dose administration were 135.17 ± 120.03 and 751.9 ± 679.74 ng/mL for unconjugated and total NV-52, respectively. Multiple-dose administration did not significantly alter the pharmacokinetics of NV-52. Renal elimination accounted for about 20–35% of the total (largely conjugated) drug but only 1% of unconjugated NV-52.

Conclusions: Plasma concentrations of unconjugated NV-52 following single-and multiple-dose administration were well above the range found to be associated with suppression of colitis in a murine model of IBD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Table I
Fig. 2
Fig. 3
Table II
Fig. 4
Fig. 5

Similar content being viewed by others

Notes

  1. The use of trade names is for product identification purposes only and does not imply endorsement

References

  1. Middleton Jr E, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflam-mation, heart disease, and cancer. Pharmacol Rev 2000; 52 (4): 673–751

    PubMed  CAS  Google Scholar 

  2. Howes JB, Tran D, Howes LG. Effects of dietary supplementation with isoflavones from red clover on ambulatory blood pressure and endothelial function in postmenopausal type 2 diabetics. Diab Obes Metab 2003; 5: 325–32

    Article  CAS  Google Scholar 

  3. Lam AN, Demasi M, James MJ, et al. Effect of red clover isoflavones on COX-2 activity in murine and human monocyte/macrophage cells Nutr Cancer 2004; 49 (1): 89–93

    Article  PubMed  CAS  Google Scholar 

  4. Huang Y, Cao S, Nagamani M, et al. Decreased circulating levels of tumor necrosis factor-alpha in postmenopausal women during consumption of soy-containing isoflavones. J Clin Endocrinol Metab 2005; 90 (7): 3956–62

    Article  PubMed  CAS  Google Scholar 

  5. Verdrengh M, Jonsson IM, Holmdahl R, et al. Genistein as an anti-inflammatory agent. Inflamm Res 2003; 52 (8): 341–6

    Article  PubMed  CAS  Google Scholar 

  6. Duan W, Kuo IC, Selvarajan S, et al. Antiinflammatory effects of genistein, a tyrosine kinase inhibitor, on a guinea pig model of asthma. Am J Resp Crit Care Med 2003; 167 (2): 185–92

    Article  PubMed  Google Scholar 

  7. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 2007; 117 (3): 514–21

    Article  PubMed  CAS  Google Scholar 

  8. Podolsky DK. The current future understanding of inflammatory bowel disease. Best Pract Res Clin Gastroenterol 2002; 16: 933–43

    Article  PubMed  Google Scholar 

  9. Feagan BG. Maintenance therapy for inflammatory bowel disease. Am J Gastroenterol 2003; 98 (12 Suppl.): S6–S17

    Article  PubMed  Google Scholar 

  10. Howes LG, James MJ, Florin T, et al. NV-52: a novel flavonoid anti-inflammatory thromboxane synthase inhibitor for the treatment of inflammatory bowel disease. Curr Opin Invest Drugs 2007; 16: 1255–66

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The conduct of this study was funded by the drug sponsor, Novogen Pty Ltd. Prof. Laurence G. Howes has previously acted as a paid consultant to Novogen Pty Ltd. The other authors have no conflicts of interest that are directly relevant to the content of this study.

Author information

Authors and Affiliations

  1. Bond University Medical School, Gold Coast, Queensland, Australia

    Laurence G. Howes

  2. ACL Statistics Pty Ltd, Hope Island, Queensland, Australia

    Jan B. Howes

  3. Novogen Pty Ltd, North Ryde, Sydney, New South Wales, Australia

    Jiu Li Huang & Catherine Walker

Authors
  1. Laurence G. Howes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jan B. Howes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jiu Li Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Catherine Walker
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Laurence G. Howes.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Howes, L.G., Howes, J.B., Huang, J.L. et al. Phase Ib Single- and Multiple-Dose Pharmacokinetic Study of Oral NV-52 in Healthy Volunteers. Drugs R D 9, 159–166 (2008). https://doi.org/10.2165/00126839-200809030-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-200809030-00003

Keywords

Search

Navigation